Press

“May Health Announces Data From Feasibility Studies of its Novel Ovarian Rebalancing™ Treatment and Receives Approval From FDA for Pivotal Trial”

“May Health Completes Treatment of Five Participants in U.S. Feasibility Study of its Ovarian Rebalancing Treatment for PCOS-related Infertility”

December 20, 2022

“May Health Solidifies Veteran Executive Team with Appointment of Women’s Health Care Leader Anne Morrissey as CEO”

September 9, 2022